Email Alert RSS
Volume 15 Issue 2
Mar.  2024
Turn off MathJax
Article Contents
Abstract
References
Related Articles
JIANG Yubin, WANG Xingming, ZHANG Yue, ZHOU Zhiqiang, YANG Jianjun. Esketamine Improves Working Memory Impairment in Neuropathic Mice Through Hippocampal BDNF-TrkB Pathway[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 328-334. DOI: 10.12290/xhyxzz.2023-0581
Citation: JIANG Yubin, WANG Xingming, ZHANG Yue, ZHOU Zhiqiang, YANG Jianjun. Esketamine Improves Working Memory Impairment in Neuropathic Mice Through Hippocampal BDNF-TrkB Pathway[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 328-334. DOI: 10.12290/xhyxzz.2023-0581
shu

Esketamine Improves Working Memory Impairment in Neuropathic Mice Through Hippocampal BDNF-TrkB Pathway

  • 1.

    Department of Anesthesiology, General Hospital of Eastern Theater Command of Chinese People's Liberation Army, The First School of Clinical Medicine, Southern Medical University, Nanjing 210002, China

  • 2.

    Department of Anesthesiology, Pain and Perioperative Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China

  • 3.

    Department of Anesthesiology, General Hospital of Eastern Theater Command of Chinese People's Liberation Army, Nanjing University, Nanjing 210002, China

Funds: 

Jointly Constructed Project of Henan Province Medical Science and Technology Tackling Key Issues Plan LHGJ20230212

More Information
  • Corresponding author:

    ZHOU Zhiqiang, E-mail: zq_zhou@sina.com

  • Received Date: November 29, 2023
  • Accepted Date: January 08, 2024
  • Available Online: February 25, 2024
  • Issue Publish Date: March 29, 2024
    Graphical Abstract
    • Abstract
  •   Objective  To explore the effect of esketamine on working memory impairment in neuropathic mice and its underlying mechanism.
      Methods  Fifty clean grade male C57BL/6J mice (2 months) were divided into 5 groups by random number table method: sham+saline (SN group), CCI+saline (CN group), CCI+esketamine(CE group), CCI+ANA-12 (CA group), CCI+ANA-12+esketamine (CAE group), with 10 mice in each group. Chronic constriction injury (CCI) was employed to establish a neuropathic pain model. On the 16th day after modeling, CE group and CAE group were administered ketamine (10 mg/kg), CAE group received ANA-12 (0.5 mg/kg) half an hour before ketamine injection, CA group was only given ANA-12, and SN group and CN group received an equivalent volume of saline. The administration was done through intraperitoneal injection for 5 consecutive days. The open-field test (OFT), paw withdrawal threshold (PWT), paw withdrawal latency (PWL) and Y-maze test were performed from day 21 after surgery. Bromo-2-deoxyUridine (BrdU) was dissolved in saline and intraperitoneally injected into the mice on days 21 to 23 after the surgery. Western blot was performed to determine the expression of Brain-derived neurotrophic factor(BDNF) in hippocampus, the immunofluorescence was performed to determine the number of BrdU and doublecortxin (DCX) positive cells in the dentate gyrus (DG) area of hippocampal.
      Results  Compared with SN group, the other four groups showed significant reductions in both PWT and PWL on day 21 after surgery (all P<0.05); There was no significant difference in the total distance travelled by the 5 groups of mice (P=0.142); In the Y maze test, compared to SN group, the accurate percentage of spontaneous alternation in CN group showed significant reductions (P<0.001), which was reversed by esketamine administration (P<0.001); compared with CE group, there was a significant reduction of the accurate percentage of spontaneous alternation in CAE group (P=0.004). The expression of BDNF protein in CN group was lower than that in SN group (P=0.021) and CE group (P=0.030), and compared with CE group, the expression of BDNF was significant decreased in CEA group (P=0.043). The number of BrdU positive and DCX positive cells significantly reduced in the DG area of the hippocampus in CN group compared to SN group (P=0.025) and CE group (P=0.003). The number of BrdU positive and DCX positive cells in CAE group significantly reduced in the DG region of the hippocampus compared to CE group (P=0.014).
      Conclusion  Esketamine maybe improve working memory impairment in neuropathic mice and the neurogenesis in dentate gyrus area of hippocampal through the BDNF-TrkB pathway.
    • FullText(HTML)
    • References (24)
  • [1]
    Mazza S, Frot M, Rey A E. A comprehensive literature review of chronic pain and memory[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2018, 87(Pt B): 183-192.
    [2]
    Miller E K, Lundqvist M, Bastos A M. Working memory 2.0[J]. Neuron, 2018, 100(2): 463-475. DOI: 10.1016/j.neuron.2018.09.023
    [3]
    Berryman C, Stanton T R, Jane Bowering K, et al. Evid-ence for working memory deficits in chronic pain: a systematic review and meta-analysis[J]. Pain, 2013, 154(8): 1181-1196. DOI: 10.1016/j.pain.2013.03.002
    [4]
    Zhang G F, Zhou Z Q, Guo J, et al. Histone deacetylase 3 in hippocampus contributes to memory impairment after chronic constriction injury of sciatic nerve in mice[J]. Pain, 2021, 162(2): 382-395. DOI: 10.1097/j.pain.0000000000002056
    [5]
    Wei Y, Chang L J, Hashimoto K. Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor[J]. Mol Psychiatry, 2022, 27(1): 559-573. DOI: 10.1038/s41380-021-01121-1
    [6]
    Wei Y, Chang L J, Hashimoto K. A historical review of antidepressant effects of ketamine and its enantiomers[J]. Pharmacol Biochem Behav, 2020, 190: 172870. DOI: 10.1016/j.pbb.2020.172870
    [7]
    Zhang C, He J Q, Shi Q Y, et al. Subanaesthetic dose of esketamine during induction delays anaesthesia recovery a randomized, double-blind clinical trial[J]. BMC Anesthesiol, 2022, 22(1): 138. DOI: 10.1186/s12871-022-01662-0
    [8]
    Hashimoto K. Arketamine for cognitive impairment in psychiatric disorders[J]. Eur Arch Psychiatry Clin Neurosci, 2023, 273(7): 1513-1525. DOI: 10.1007/s00406-023-01570-5
    [9]
    Zhang K, Yao Y T, Hashimoto K. Ketamine and its metabolites: potential as novel treatments for depression[J]. Neuropharmacology, 2023, 222: 109305. DOI: 10.1016/j.neuropharm.2022.109305
    [10]
    Xia S H, Hu S W, Ge D G, et al. Chronic pain impairs memory formation via disruption of neurogenesis mediated by mesohippocampal brain-derived neurotrophic factor signaling[J]. Biol Psychiatry, 2020, 88(8): 597-610. DOI: 10.1016/j.biopsych.2020.02.013
    [11]
    Wu A B, Zhang J Y. Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis[J]. J Neuroinflammation, 2023, 20(1): 283. DOI: 10.1186/s12974-023-02964-x
    [12]
    Wang X M, Zhang G F, Jia M, et al. Environmental enrichment improves pain sensitivity, depression-like phenotype, and memory deficit in mice with neuropathic pain: role of NPAS4[J]. Psychopharmacology (Berl), 2019, 236(7): 1999-2014. DOI: 10.1007/s00213-019-5187-6
    [13]
    Hussain G, Akram R, Anwar H, et al. Adult neurogenesis: a real hope or a delusion?[J]. Neural Regen Res, 2024, 19(1): 6-15. DOI: 10.4103/1673-5374.375317
    [14]
    Jaberi S, Fahnestock M. Mechanisms of the beneficial effects of exercise on brain-derived neurotrophic factor expression in Alzheimer's disease[J]. Biomolecules, 2023, 13(11): 1577. DOI: 10.3390/biom13111577
    [15]
    李亚南, 张琦, 于家旭, 等. BDNF/TrkB信号通路在预先注射青年大鼠血浆减轻七氟烷诱发老龄大鼠认知功能障碍中的作用[J]. 中华麻醉学杂志, 2022, 42(5): 546-550.

    Li Y N, Zhang Q, Yu J X, et al. Role of BDNF/TrkB signaling pathway in pre-injection of young rat plasma-induced reduction of sevoflurane-caused cognitive dysfunc-tion in aged rats[J]. Chin J Anesthesiol, 2022, 42(5): 546-550.
    [16]
    Fabrazzo M, Cipolla S, Pisaturo M, et al. Bidirectional relationship between HIV/HBV infection and comorbid depres-sion and/or anxiety: a systematic review on shared biological mechanisms[J]. J Pers Med, 2023, 13(12): 1689. DOI: 10.3390/jpm13121689
    [17]
    Pettorruso M, Miuli A, Clemente K, et al. Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder[J/OL]. Mol Psychiatry. https://doi.org/10.1038/s41380-023-02367-7. doi: 10.1038/s41380-023-02367-7.
    [18]
    Zhang S X, Chen Y R, Wang Y J, et al. Tau accumulation in the spinal cord contributes to chronic inflammatory pain by upregulation of IL-1β and BDNF[J/OL]. Neurosci Bull. https://doi.org/10.1007/s12264-023-01152-4. doi: 10.1007/s12264-023-01152-4.
    [19]
    Cook A A, Leung T C S, Rice M, et al. Endosomal dysfunction contributes to cerebellar deficits in spinocerebellar ataxia type 6[J]. Elife, 2023, 12: RP90510. DOI: 10.7554/eLife.90510
    [20]
    Borsellino P, Krider R I, Chea D, et al. Ketamine and the disinhibition hypothesis: neurotrophic factor-mediated treatment of depression[J]. Pharmaceuticals (Basel), 2023, 16(5): 742.
    [21]
    Medeiros G C, Gould T D, Prueitt W L, et al. Blood-based biomarkers of antidepressant response to ketamine and esketamine: a systematic review and meta-analysis[J]. Mol Psychiatry, 2022, 27(9): 3658-3669.
    [22]
    Zeng J S, Xie Z Q, Chen L, et al. Rosmarinic acid alleviate CORT-induced depressive-like behavior by promoting neurogenesis and regulating BDNF/TrkB/PI3K signaling axis[J]. Biomed Pharmacother, 2024, 170: 115994.
    [23]
    Huang E J, Reichardt L F. Trk receptors: roles in neuronal signal transduction[J]. Annu Rev Biochem, 2003, 72: 609-642.
    [24]
    Carvalho A L, Caldeira M V, Santos S D, et al. Role of the brain-derived neurotrophic factor at glutamatergic synapses[J]. Br J Pharmacol, 2008, 153(Suppl 1): S310-S324.
    • Related Articles

  • Related Articles

    [1]WEN Bei, ZHU He, XU Li, HUANG Yuguang. Association Between Coffee Consumption and Pain: A Cross-sectional Study Based on American National Health and Nutrition Examination Survey[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 351-358. DOI: 10.12290/xhyxzz.2023-0553
    [2]2024 Consensus Working Group on Chronic Pain Management Through Spinal Cord Electrical Stimulation in China and the United States. 2024 Consensus Guidelines on Spinal Cord Stimulation for Chronic Pain Management Among Practicing Pain Physicians in China and the United States[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 285-293. DOI: 10.12290/xhyxzz.2024-0033
    [3]SONG Shujia, SUN Chen, PEI Lijian, XU Weihai, HUANG Yuguang. Progress in Diagnosis and Treatment of Central Post-stroke Pain[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 265-271. DOI: 10.12290/xhyxzz.2023-0591
    [4]JIANG Yubin, WANG Xingming, ZHANG Yue, ZHOU Zhiqiang, YANG Jianjun. Esketamine Improves Working Memory Impairment in Neuropathic Mice Through Hippocampal BDNF-TrkB Pathway[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/j.issn.1674-9081.2023-0581
    [5]SONG Shujia, PEI Lijian, XU Yan, ZHANG Xue, HUANG Yuguang. Research Progress on the Animal Models of Neuromyelitis Optica Spectrum Disorders-related Neuropathic Pain[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 598-602. DOI: 10.12290/xhyxzz.2022-0647
    [6]Working Committee on Doctor-patient Relationship, Chinese Psychiatrist Association, Chinese Medical Doctor Association, WEI Jing, HE Yan-ling. Consensus of Chinese Experts on the Work and Demonstration of Online Balint Groups[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 33-37. DOI: 10.3969/j.issn.1674-9081.2020.00.011
    [7]Zhao-jing XUE, Le SHEN, Zhi-yao WANG, Yu-guang HUANG. Feasibility of Signal Transducers and Activators of Transcription 3 Inhibitor WP1066 as a Novel Target for Neuropathic Pain[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(2): 142-147. DOI: 10.3969/j.issn.1674-9081.2014.02.003
    [10]Xu LI, Le SHEN, Li XU, Wei LIU, Xue-rong YU, Yu-guan HUANG. Small Interfering RNA-mediated Selective Knockdown of Postsynaptic Density Protein 95 Reverses Mechanical Allodynia in Neuropathic Pain Rats[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(4): 343-349. DOI: 10.3969/j.issn.1674-9081.2011.04.012

  • Cited by

    Periodical cited type(1)

    1. 张莹莹，赵力波，贾霜，李玲梅. 5-羟色胺和去甲肾上腺素再摄取抑制剂类药物在神经病理性疼痛中的临床应用进展. 中外医药研究. 2024(13): 162-164 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1273) PDF downloads (21) Cited by(2)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close